Slingshot members are tracking this event:
LUXTURNA (voretigene neparvovec) gene therapy for the treatment of patients with vision loss due to Leber congenital amaurosis PDUFA date set for Jan. 12, 2018.
Slingshot Insights Explained
Dec 19, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Luxturna, Voretigene Neparvovec, First Gene Therapy, Vision Loss, Leber Congenital Amaurosis, Retinitis Pigmentosa